Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)

Next Previous
X
Search
Trial Profile

Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Feb 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Acute heart failure; Decompensated heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms ASCEND-HF
  • Sponsors Janssen-Cilag; Scios

    • Most Recent Events

    • 01 Jan 2023 Results (n=5741) comparing NYHA Class and patient-reported health outcomes in cohort of patients hospitalized for heart failure, majority of patients exhibited discordance between clinician-reported NYHA class published in the Circulation: Heart Failure
    • 01 Dec 2022 Results of an analysis comparing patient-reported and clinical outcomes between patients hospitalized with HFrEF vs HFpEF published in the Journal of Cardiac Failure
    • 07 Nov 2022 Results (n=5741) Comparing Patient Reported Outcomes and New York Heart Association Class Among Patients Hospitalized for Heart Failure presented at the American Heart Association Scientific Sessions 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top